Tag - COVID-19

Public Safety-oriented information and resources on the Novel Coronavirus COVID-19.

May 10, 2021Read more...

J&J (Janssen) COVID-19 Vaccination Restart

After about a 10 day pause in the Johnson and Johnson (Janssen) Vaccine being administered in the US, on April 23, the Advisory Committee for Immunization Practice (APIC), recommended to the CDC & FDA to restart J&J vaccinations again.  The pause was due to reports of multiple cases of a new syndrome that identified as an apparently rare cerebral venous sinus thrombosis with thrombocytopenia, later called TTS, and potentially associated with the J&J COVID-19 vaccine. This turned out to be...

April 23, 2021Read more...

FDA & CDC Recommend Pause in Johnson & Johnson (J&J) Vaccinations

THE FDA & CDC have recommended a pause in administering J&J (Janssen) COVID vaccinations after the VAERS (Vaccine Adverse Event Reporting System) had reports of six (6) women, between the ages of 18 and 48, developing a rare type of blood clot between 6 & 13 days after receiving the J&J vaccine.  This article contains an overview of the HAN Alert Recommendation and why it is so important, some information about this rare clot, adenovirus- vector COVID vaccines, a chart...